Skip to main content
Erschienen in: The Cerebellum 3/2019

01.06.2019 | Original Paper

What Is Behind Cerebellar Vertigo and Dizziness?

verfasst von: Katharina Feil, Ralf Strobl, Alexander Schindler, Siegbert Krafczyk, Nicolina Goldschagg, Claudia Frenzel, Miriam Glaser, Florian Schöberl, Andreas Zwergal, Michael Strupp

Erschienen in: The Cerebellum | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

The differential diagnosis of vertigo or dizziness as a result of cerebellar disorders can be difficult as many patients with a cerebellar pathology do not present with the full spectrum of cerebellar signs. The main goal of this study was to describe the typical clinical features of these patients with vertigo or dizziness of a cerebellar origin. We reviewed the medical records of 5400 patients with vertigo and dizziness from our tertiary outpatient clinic for vertigo and balance disorders. In 459 the diagnosis of “cerebellar vertigo or dizziness” was made; 90 patients were excluded from further analysis due to evident structural changes in MRI. Of the remaining 369 patients (67.0 ± 15.1, 54% female, symptom duration until diagnosis 5.5 ± 6.9 years), 81% suffered from persistent vertigo or dizziness, 31% from attacks of vertigo and dizziness and 21% from both. Neuro-ophthalmologically, 95% had saccadic smooth pursuit, 80% gaze-holding deficits, 64% a pathological fixation suppression of the VOR, 24% central fixation nystagmus (in 64% of these cases downbeat nystagmus (DBN)), 23% rebound nystagmus, and an ocular misalignment in 84% in near view and 50% in distance view. Eleven percent had isolated mild to moderate cerebellar ocular motor disturbances without any other typical cerebellar signs. The most common diagnoses were sporadic adult-onset degenerative ataxia in 26%; idiopathic DBN syndrome in 20%; cerebellar ataxia, neuropathy, and vestibular areflexia syndrome in 10%; episodic ataxia type 2 in 7%; and multiple system atrophy cerebellar type in 6%. In posturography, a typical cerebellar 3-Hz sway was found in 16%. The diagnostic key to patients with cerebellar vertigo or dizziness is a careful examination of eye movements since practically all of them have cerebellar ocular disturbances.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Corrales CE, Bhattacharyya N. Dizziness and death: an imbalance in mortality. Laryngoscope. 2016;126(9):2134–6.CrossRefPubMed Corrales CE, Bhattacharyya N. Dizziness and death: an imbalance in mortality. Laryngoscope. 2016;126(9):2134–6.CrossRefPubMed
2.
Zurück zum Zitat Brandt T, Dieterich M, Strupp M. Vertigo and dizziness - common complaints, Vol. 2. Springer; 2013. Brandt T, Dieterich M, Strupp M. Vertigo and dizziness - common complaints, Vol. 2. Springer; 2013.
3.
Zurück zum Zitat Kim JS, Lee H. Vertigo due to posterior circulation stroke. Semin Neurol. 2013;33(3):179–84.CrossRefPubMed Kim JS, Lee H. Vertigo due to posterior circulation stroke. Semin Neurol. 2013;33(3):179–84.CrossRefPubMed
5.
Zurück zum Zitat Grimaldi G, Manto M. Topography of cerebellar deficits in humans. Cerebellum. 2012;11(2):336–51.CrossRefPubMed Grimaldi G, Manto M. Topography of cerebellar deficits in humans. Cerebellum. 2012;11(2):336–51.CrossRefPubMed
6.
Zurück zum Zitat Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15(3):369–91.CrossRefPubMedPubMedCentral Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15(3):369–91.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Leigh RJ, Zee DS, editors. The Neurology of Eye Movements. 5th ed. Oxford, New York: Oxford University Press; 2015. Leigh RJ, Zee DS, editors. The Neurology of Eye Movements. 5th ed. Oxford, New York: Oxford University Press; 2015.
8.
Zurück zum Zitat Diener HC, Dichgans J, Bacher M, Gompf B. Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol. 1984;57(2):134–42.CrossRefPubMed Diener HC, Dichgans J, Bacher M, Gompf B. Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol. 1984;57(2):134–42.CrossRefPubMed
9.
Zurück zum Zitat Baloh RW, Konrad HR, Honrubia V. Vestibulo-ocular function in patients with cerebellar atrophy. Neurology. 1975;25(2):160–8.CrossRefPubMed Baloh RW, Konrad HR, Honrubia V. Vestibulo-ocular function in patients with cerebellar atrophy. Neurology. 1975;25(2):160–8.CrossRefPubMed
10.
Zurück zum Zitat Thurston SE, Leigh RJ, Abel LA, Dell'Osso LF. Hyperactive vestibulo-ocular reflex in cerebellar degeneration: pathogenesis and treatment. Neurology. 1987;37(1):53–7.CrossRefPubMed Thurston SE, Leigh RJ, Abel LA, Dell'Osso LF. Hyperactive vestibulo-ocular reflex in cerebellar degeneration: pathogenesis and treatment. Neurology. 1987;37(1):53–7.CrossRefPubMed
11.
12.
Zurück zum Zitat Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670–6.CrossRefPubMedPubMedCentral Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670–6.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Szmulewicz DJ, Roberts L, McLean CA, MacDougall HG, Halmagyi GM, Storey E. Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Neurol Clin Pract. 2016;6(1):61–8.CrossRefPubMedPubMedCentral Szmulewicz DJ, Roberts L, McLean CA, MacDougall HG, Halmagyi GM, Storey E. Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Neurol Clin Pract. 2016;6(1):61–8.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hufner K, et al. Esophoria or esotropia in adulthood: a sign of cerebellar dysfunction? J Neurol. 2015;262(3):585–92.CrossRefPubMed Hufner K, et al. Esophoria or esotropia in adulthood: a sign of cerebellar dysfunction? J Neurol. 2015;262(3):585–92.CrossRefPubMed
15.
Zurück zum Zitat Schneider E, Villgrattner T, Vockeroth J, Bartl K, Kohlbecher S, Bardins S, et al. EyeSeeCam: an eye movement-driven head camera for the examination of natural visual exploration. Ann N Y Acad Sci. 2009;1164:461–7.CrossRefPubMed Schneider E, Villgrattner T, Vockeroth J, Bartl K, Kohlbecher S, Bardins S, et al. EyeSeeCam: an eye movement-driven head camera for the examination of natural visual exploration. Ann N Y Acad Sci. 2009;1164:461–7.CrossRefPubMed
16.
Zurück zum Zitat Bremova-Ertl T, et al. Oculomotor and vestibular findings in Gaucher disease type 3 and their correlation with neurological findings. Front Neurol. 2017;8:711.CrossRefPubMed Bremova-Ertl T, et al. Oculomotor and vestibular findings in Gaucher disease type 3 and their correlation with neurological findings. Front Neurol. 2017;8:711.CrossRefPubMed
17.
Zurück zum Zitat Strupp M, Kim JS, Murofushi T, Straumann D, Jen JC, Rosengren SM, et al. Bilateral vestibulopathy: diagnostic criteria consensus document of the classification Committee of the Barany Society. J Vestib Res. 2017;27(4):177–89.CrossRefPubMed Strupp M, Kim JS, Murofushi T, Straumann D, Jen JC, Rosengren SM, et al. Bilateral vestibulopathy: diagnostic criteria consensus document of the classification Committee of the Barany Society. J Vestib Res. 2017;27(4):177–89.CrossRefPubMed
18.
Zurück zum Zitat Krafczyk S, Tietze S, Swoboda W, Valkovič P, Brandt T. Artificial neural network: a new diagnostic posturographic tool for disorders of stance. Clin Neurophysiol. 2006;117(8):1692–8.CrossRefPubMed Krafczyk S, Tietze S, Swoboda W, Valkovič P, Brandt T. Artificial neural network: a new diagnostic posturographic tool for disorders of stance. Clin Neurophysiol. 2006;117(8):1692–8.CrossRefPubMed
19.
Zurück zum Zitat Subramony SH. SARA--a new clinical scale for the assessment and rating of ataxia. Nat Clin Pract Neurol. 2007;3(3):136–7.CrossRefPubMed Subramony SH. SARA--a new clinical scale for the assessment and rating of ataxia. Nat Clin Pract Neurol. 2007;3(3):136–7.CrossRefPubMed
21.
Zurück zum Zitat Claassen J, Feil K, Bardins S, Teufel J, Spiegel R, Kalla R, et al. Dalfampridine in patients with downbeat nystagmus--an observational study. J Neurol. 2013;260(8):1992–6.CrossRefPubMed Claassen J, Feil K, Bardins S, Teufel J, Spiegel R, Kalla R, et al. Dalfampridine in patients with downbeat nystagmus--an observational study. J Neurol. 2013;260(8):1992–6.CrossRefPubMed
22.
Zurück zum Zitat Claassen J, Spiegel R, Kalla R, Faldon M, Kennard C, Danchaivijitr C, et al. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry. 2013;84(12):1392–9.CrossRefPubMed Claassen J, Spiegel R, Kalla R, Faldon M, Kennard C, Danchaivijitr C, et al. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry. 2013;84(12):1392–9.CrossRefPubMed
23.
Zurück zum Zitat Claassen J, Teufel J, Kalla R, Spiegel R, Strupp M. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study. J Neurol. 2013;260(2):668–9.CrossRefPubMed Claassen J, Teufel J, Kalla R, Spiegel R, Strupp M. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study. J Neurol. 2013;260(2):668–9.CrossRefPubMed
24.
Zurück zum Zitat Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011;77(3):269–75.CrossRefPubMedPubMedCentral Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011;77(3):269–75.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology. 2004;62(9):1623–5.CrossRefPubMed Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology. 2004;62(9):1623–5.CrossRefPubMed
26.
Zurück zum Zitat Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology. 2003;61(2):165–70.CrossRefPubMed Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology. 2003;61(2):165–70.CrossRefPubMed
27.
Zurück zum Zitat Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, et al. Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series. J Neurol. 2013;260(10):2556–61.CrossRefPubMedPubMedCentral Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, et al. Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series. J Neurol. 2013;260(10):2556–61.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Li X, Wang Y, Wang Z, Xu Y, Zheng W. 3-Hz postural tremor in multiple system atrophy cerebellar type (MSA-C)-a static posturography study. Neurol Sci. 2018;39(1):71–7.CrossRefPubMed Li X, Wang Y, Wang Z, Xu Y, Zheng W. 3-Hz postural tremor in multiple system atrophy cerebellar type (MSA-C)-a static posturography study. Neurol Sci. 2018;39(1):71–7.CrossRefPubMed
30.
Zurück zum Zitat Kirchner H, Kremmyda O, Hüfner K, Stephan T, Zingler V, Brandt T, et al. Clinical, electrophysiological, and MRI findings in patients with cerebellar ataxia and a bilaterally pathological head-impulse test. Ann N Y Acad Sci. 2011;1233:127–38.CrossRefPubMed Kirchner H, Kremmyda O, Hüfner K, Stephan T, Zingler V, Brandt T, et al. Clinical, electrophysiological, and MRI findings in patients with cerebellar ataxia and a bilaterally pathological head-impulse test. Ann N Y Acad Sci. 2011;1233:127–38.CrossRefPubMed
31.
Zurück zum Zitat Bronstein AM, Hood JD. Cervical nystagmus due to loss of cerebellar inhibition on the cervico-ocular reflex: a case report. J Neurol Neurosurg Psychiatry. 1985;48(2):128–31.CrossRefPubMedPubMedCentral Bronstein AM, Hood JD. Cervical nystagmus due to loss of cerebellar inhibition on the cervico-ocular reflex: a case report. J Neurol Neurosurg Psychiatry. 1985;48(2):128–31.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Yu-Wai-Man P, Gorman G, Bateman DE, Leigh RJ, Chinnery PF. Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6. J Neurol. 2009;256(1):78–82.CrossRefPubMed Yu-Wai-Man P, Gorman G, Bateman DE, Leigh RJ, Chinnery PF. Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6. J Neurol. 2009;256(1):78–82.CrossRefPubMed
Metadaten
Titel
What Is Behind Cerebellar Vertigo and Dizziness?
verfasst von
Katharina Feil
Ralf Strobl
Alexander Schindler
Siegbert Krafczyk
Nicolina Goldschagg
Claudia Frenzel
Miriam Glaser
Florian Schöberl
Andreas Zwergal
Michael Strupp
Publikationsdatum
01.06.2019
Verlag
Springer US
Erschienen in
The Cerebellum / Ausgabe 3/2019
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-018-0992-8

Weitere Artikel der Ausgabe 3/2019

The Cerebellum 3/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.